Stockreport

Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Cytek Biosciences, Inc.  (CTKB) 
PDF Profit margin: 1.8% (up from net loss in 3Q 2023). The move to profitability was primarily driven by higher revenue. EPS: US$0.007 (up from US$0.047 loss in 3Q 2023). [Read more]